Let's focus on this: MIRAMAR, FL, July 27, 2020
Post# of 36537
(Total Views: 258)
Posted On: 08/13/2020 2:46:47 PM
Let's focus on this:
MIRAMAR, FL, July 27, 2020 - Generex Biotechnology Corporation (www.generex.com)
(OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the
FDA has accepted their pre-IND briefing package for the Ii-Key-SARS-CoV-2 coronavirus
prophylactic vaccine, and will provide a written response by August 24, 2020.
We need this and promising test results for Covid-19. Those two things happen, I suspect we'll be good. We don't have to be first or second but we need to finish the race.
MIRAMAR, FL, July 27, 2020 - Generex Biotechnology Corporation (www.generex.com)
(OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the
FDA has accepted their pre-IND briefing package for the Ii-Key-SARS-CoV-2 coronavirus
prophylactic vaccine, and will provide a written response by August 24, 2020.
We need this and promising test results for Covid-19. Those two things happen, I suspect we'll be good. We don't have to be first or second but we need to finish the race.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼